<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04593524</url>
  </required_header>
  <id_info>
    <org_study_id>USU 2</org_study_id>
    <nct_id>NCT04593524</nct_id>
  </id_info>
  <brief_title>The Role of Vitamin D, A, and Beta Carotene in Tuberculosis Patients With Vitamin D Receptor Gene Polymorphism</brief_title>
  <official_title>The Role of Vitamin D, A, and Beta Carotene in Tuberculosis Patients With Vitamin D Receptor Gene Polymorphism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitas Sumatera Utara</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitas Sumatera Utara</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recent studies showed that vitamin D and A has an effect in improving sputum conversion in&#xD;
      tuberculosis. This study aims to find out the effect of vitamin D 1000 IU and A 6000 IU&#xD;
      supplementation on Tuberculosis patients with vitamin D receptor gene polymorphism, who live&#xD;
      in North Sumatera, Indonesia. This study is a randomized control clinical trial, with 48&#xD;
      tuberculosis patients with vitamin D receptor gene polymorphism which are TaqI and FokI&#xD;
      participating, divided into two groups, each with 24 participants, which are treatment group&#xD;
      (I) which receives nutritional counseling, vitamin D 1000 IU, vitamin A 6000 IU, and control&#xD;
      group (C) which only receives nutritional counseling for 28 days. Patients who participated&#xD;
      was found to be heterozygous with TaqI (T&gt;C) or FokI (C&gt;T) genotype variants.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recent studies showed that vitamin D and A has an effect in improving sputum conversion in&#xD;
      tuberculosis. This study aims to find out the effect of vitamin D 1000 IU and A 6000 IU&#xD;
      supplementation on Tuberculosis patients with vitamin D receptor gene polymorphism, who live&#xD;
      in North Sumatera, Indonesia. This study is a randomized control clinical trial, with 48&#xD;
      tuberculosis patients with vitamin D receptor gene polymorphism which are TaqI and FokI&#xD;
      participating, divided into two groups, each with 24 participants, which are treatment group&#xD;
      (I) which receives nutritional counseling, vitamin D 1000 IU, vitamin A 6000 IU, and control&#xD;
      group (C) which only receives nutritional counseling for 28 days. Patients who participated&#xD;
      was found to be heterozygous with TaqI (T&gt;C) or FokI (C&gt;T) genotype variants. The result of&#xD;
      this study showed that at the start, serum 25(OH)D levels in group I were lower compared to&#xD;
      group C (19.746.59 ng/mL vs 25.21±7.57 ng/mL). Group I showed significant correlation between&#xD;
      vitamin D level categories with sputum conversion (mean: standard deviation= 2.25±0.68&#xD;
      weeks). Supplementation of vitamin D 1000 IU provides an accelerated sputum conversion in&#xD;
      tuberculosis patients with vitamin D receptor gene polymorphism.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 14, 2019</start_date>
  <completion_date type="Actual">September 22, 2019</completion_date>
  <primary_completion_date type="Actual">August 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>vitamin D</measure>
    <time_frame>up to 4 weeks</time_frame>
    <description>25(OH)D serum level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>vitamin A</measure>
    <time_frame>up to 4 weeks</time_frame>
    <description>vitamin A serum level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>beta carotene</measure>
    <time_frame>up to 4 weeks</time_frame>
    <description>beta carotene</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Tuberculosis</condition>
  <arm_group>
    <arm_group_label>Treatment Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>24 participants, which are treatment group (I) which receives nutritional counseling, vitamin D 1000 IU, vitamin A 6000 IU</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Counseling Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>24 participants which only receives nutritional counseling for 28 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin D 1000 IU and A 6000 IU supplementation and nutritional counseling</intervention_name>
    <description>24 participants, which are treatment group (I) which receives nutritional counseling, vitamin D 1000 IU, vitamin A 6000 IU</description>
    <arm_group_label>Treatment Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>nutritional Counseling</intervention_name>
    <description>control group (C) which only receives nutritional counseling for 28 days</description>
    <arm_group_label>Counseling Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The inclusion criteria are males or females, which have new case lung tuberculosis&#xD;
             infection with acid fast bacilli (AFB) result (+), aged 18-60 years, heterozygote&#xD;
             genotype test on one of the genes TaqI and FokI, willing to participate in the study&#xD;
             and complete the informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The exclusion criteria are pregnant, found to have comorbidities such as diabetes&#xD;
             mellitus or Human Immunodeficiency Virus (+), and Tuberculosis on category II.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Mrs / Miss</gender_description>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Faculty of Medicine Universitas Sumatera Utara</name>
      <address>
        <city>Medan</city>
        <state>North Sumatra</state>
        <zip>20155</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 29, 2020</study_first_submitted>
  <study_first_submitted_qc>October 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 20, 2020</study_first_posted>
  <last_update_submitted>October 13, 2020</last_update_submitted>
  <last_update_submitted_qc>October 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitas Sumatera Utara</investigator_affiliation>
    <investigator_full_name>DINA KEUMALA SARI</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>25(OH)D serum</keyword>
  <keyword>calcium</keyword>
  <keyword>counseling</keyword>
  <keyword>FokI</keyword>
  <keyword>retinol</keyword>
  <keyword>TaqI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 9, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/24/NCT04593524/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>May 9, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/24/NCT04593524/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

